As the Trump administration continues to redefine priorities and research around autism, keeping the industry on edge, other pressure points for providers and investors are also mounting in 2025. Network tightening, payer scrutiny, complexity in authorizations and uncertainty in staffing are creating hurdles for reimbursement negotiations, industry leaders explained at the Autism Investor Summit in April. “Naturally, as providers, we think about having adversarial relationships with payers. … Sometimes it gets adversarial, but generally, the best path is building relationships with your payers, communicating value, communicating your outcomes and why you are the best in their network,” Jonathan Mueller, founder and Co-CEO of Element RCM and Ascend Behavior Partners, said.
Read the full article: Outcomes Over Output: What’s Shaping Autism Therapy Reimbursement in 2025 //
Source: https://bhbusiness.com/2025/06/02/outcomes-over-output-whats-shaping-autism-therapy-reimbursement-in-2025/